ENDOTHELIAL ACTIVATION IS REDUCED BY HYDROXYUREA THERAPY AND PREDICTS TRANSCRANIAL DOPPLER VELOCITY IN THE NOHARM STUDY: A PROSPECTIVE CLINICAL TRIAL OF HYDROXYUREA IN UGANDAN CHILDREN WITH SICKLE CELL ANEMIA

被引：0
|
作者：
Siegert, Thomas F. [1 ]
Opoka, Robert O. [2 ]
Latham, Teresa [3 ]
Lane, Adam [3 ]
Ware, Russell E. [4 ]
John, Chandy C. [5 ]
Conroy, Andrea [5 ]
机构：
[1] Brown Univ, Dept Pediat, Warren Alpert Med Sch, Div Pediat Med, Providence, RI 02912 USA
[2] Makerere Univ, Coll Hlth Sci, Dept Paediat & Child Hlth, Kampala, Uganda
[3] Univ Cincinnati, Cincinnati Childrens Hosp Med Ctr, Coll Med, Cincinnati, OH USA
[4] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Div Hematol, Cincinnati, OH 45229 USA
[5] Indiana Univ Sch Med, Ryan White Ctr Pediat Infect Dis & Global Hlth, Dept Pediat, Indianapolis, IN 46202 USA
来源：
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE | 2021年 / 105卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
1212
引用
收藏
页码：387 / 388
页数：2
相关论文
共 41 条
  • [1] Hydroxyurea therapy lowers transcranial Doppler flow velocity in children with sickle cell anemia.
    Zimmerman, SA
    Schultz, WH
    Mortier, NA
    Davis, JS
    Ware, RE
    [J]. BLOOD, 2003, 102 (11) : 44A - 45A
  • [2] Hydroxyurea therapy lowers transcranial doppler velocities in children with sickle cell anemia
    Zimmerman, SA
    Davis, JS
    Schultz, WH
    Ware, RE
    [J]. PEDIATRIC RESEARCH, 2002, 51 (04) : 231A - 231A
  • [3] Hydroxyurea therapy lowers transcranial Doppler flow velocities in children with sickle cell anemia
    Zimmerman, Sherri A.
    Schultz, William H.
    Burgett, Shelly
    Mortier, Nicole A.
    Ware, Russell E.
    [J]. BLOOD, 2007, 110 (03) : 1043 - 1047
  • [4] Pharmacokinetics of Hydroxyurea Therapy in African Children with Sickle Cell Anemia: A Noharm Ancillary PK Study
    Marahatta, Anu
    Dong, Min
    Opoka, Robert
    McElhinney, Kathryn E.
    Latham, Teresa S.
    John, Chandy C.
    Vinks, Alexander A.
    Ware, Russell E.
    [J]. BLOOD, 2017, 130
  • [5] Novel use Of Hydroxyurea in an African Region with Malaria (NOHARM): a trial for children with sickle cell anemia
    Opoka, Robert O.
    Ndugwa, Christopher M.
    Latham, Teresa S.
    Lane, Adam
    Hume, Heather A.
    Kasirye, Phillip
    Hodges, James S.
    Ware, Russell E.
    John, Chandy C.
    [J]. BLOOD, 2017, 130 (24) : 2585 - 2593
  • [6] Hydroxyurea to lower transcranial Doppler velocities and prevent primary stroke: the Uganda NOHARM sickle cell anemia cohort
    Opoka, Robert O.
    Hume, Heather A.
    Latham, Teresa S.
    Lane, Adam
    Williams, Olatundun
    Tymon, Jennifer
    Nakafeero, Maria
    Kasirye, Phillip
    Ndugwa, Christopher M.
    John, Chandy C.
    Ware, Russell E.
    [J]. HAEMATOLOGICA, 2020, 105 (06) : E272 - E275
  • [7] Hydroxyurea therapy lowers transcranial doppler flow velocities in children with sickle cell anemia.
    Zimmerman, SA
    Schultz, WH
    Davis, JS
    Ware, RE
    [J]. BLOOD, 2002, 100 (11) : 10A - 10A
  • [8] Hydroxyurea Improves Intelligence Quotient Scores in Children with Sickle Cell Anemia and Elevated Transcranial Doppler Velocity
    Rankine-Mullings, Aangela E.
    Soares, Deanne
    Aldred, Karen
    Chang-Lopez, Susan
    Wisdom-Phipps, Margaret Elizabeth
    Schultz, William
    Latham, Teresa S.
    Stuber, Susan E.
    Jackson, Patrice
    Ware, Russell E.
    Reid, Marvin Ellsworth
    [J]. BLOOD, 2023, 142
  • [9] Prevention of conversion to abnormal transcranial Doppler with hydroxyurea in sickle cell anemia: A Phase III international randomized clinical trial
    Hankins, Jane S.
    McCarville, Mary Beth
    Rankine-Mullings, Angela
    Reid, Marvin E.
    Lobo, Clarisse L. C.
    Moura, Patricia G.
    Ali, Susanna
    Soares, Deanne P.
    Aldred, Karen
    Jay, Dennis W.
    Aygun, Banu
    Bennett, John
    Kang, Guolian
    Goldsmith, Jonathan C.
    Smeltzer, Matthew P.
    Boyett, James M.
    Ware, Russell E.
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2015, 90 (12) : 1099 - 1105
  • [10] Effect of hydroxyurea in sickle cell anemia:: A clinical trial in children and teenagers with severe sickle cell anemia and sickle cell β-thalassemia
    Koren, A
    Segal-Kupershmit, D
    Zalman, L
    Levin, C
    Abu Hana, M
    Palmor, H
    Luder, A
    Attias, D
    [J]. PEDIATRIC HEMATOLOGY AND ONCOLOGY, 1999, 16 (03) : 221 - 232
12345